Laboratorios Farma | ROVI - Sales Revenues


Laboratorios Farma reported EUR448.66M in Sales Revenues for its fiscal semester ending in December of 2023.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Almirall EUR 602.71M 55.09M Jun/2026
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Ionis Pharmaceuticals USD 268M 22M Jun/2026
IQVIA Holdings USD 4.37B 220M Jun/2026
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 100M 289M Jun/2026
Organon & Co USD 1.46B 50M Mar/2026
Pharma Mar EUR 50M 7.1M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.76B 240M Jun/2026
Xeris Pharmaceuticals USD 83.13M 2.68M Mar/2026